[CLOSED] Public consultation of the Draft Project Plan on “Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke”
We are pleased to announce that as of today the Draft Project Plan “Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke”, produced within WP5 Strand B, has entered the public consultation phase. This consultation will take place between 10/06 and 29/06/2015. Objective of Draft Project Plan The aim of the Draft Project Plan […]
HTA Core Model Version 3.0 draft – comments welcome!
Continuous improvement of the HTA Core Model – Version 3.0 has been made available as a public draft. Continuous improvement of the HTA Core Model – Version 3.0 has been made available as a public draft aiming at capturing additional feedback from outside of EUnetHTA. The current additions to a steady stream of adjustments include […]
WP7 SG2 Position paper on how to decide on the appropriate study design for AEG available
WP7 Subgroup 2 is pleased to announce the publication of the Position paper on how to decide on the appropriate study design for primary research arising from HTA reports. This document is one of two WP7 SG2 methodological documents aiming to help HTA authors/systematic reviewers in defining their recommendations for Additional Evidence Generation (AEG). This […]
The summary of the EUnetHTA-EMA face-to-face meeting on 8 May, 2015, is available
Meeting minutes from the EUnetHTA-EMA meeting that took place 8 May 2015 in London, UK, is now available. Find the minutes here. Find all minutes from EUnetHTA-EMA meetings here.
[CLOSED] Public consultation of Draft Project Plan of the sixth pilot of WP5 Strand A: Rapid Relative Effectiveness Assessment of new pharmaceuticals for the treatment of chronic hepatitis C
We are pleased to announce that as of today the Draft Project Plan regarding the production of a Rapid Relative Effectiveness Assessment of new pharmaceuticals for the treatment of chronic hepatitis C by Work Package 5 has entered the public consultation phase. This consultation phase will take place between 23 June and 7 July 2015. […]
[CLOSED] Public consultation on “the use of Intravenous immunoglobulins for Alzheimer’s disease including Mild Cognitive Impairment”
We are happy to announce that the second Core HTA produced within the EUnetHTA Joint Action 2 Work Package 4 is available for public feedback. The topic assessed is “Use of Intravenous immunoglobulins for Alzheimer’s disease including Mild Cognitive Impairment” This consultation will take place between June 18th and July 15th, 2015. Objective of public […]
The Joint Assessment on “Vorapaxar (ZONTIVITY™) for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infection (MI)” is now available
The Joint Assessment on “Vorapaxar (ZONTIVITY™) for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infection (MI)” is now available Find the Joint Assessment here.
EUnetHTA partners’ Annual Reports 2014
We are starting to provide links to the EUnetHTA partners’ Annual Reports. The links could be found via the individual profiles of the partner organisations that can be found via the Contact page. We are starting to provide links to the EUnetHTA partners’ Annual Reports. The links could be found via the individual profiles of […]
The 4th pilot rapid assessment of WP5 JA2 Strand B on “Biodegradable stents for the treatment of refractory or recurrent benign oesophageal stenosis” is now available
We are pleased to announce that the 4th pilot rapid assessment of WP5 JA2 Strand B on “Biodegradable stents for the treatment of refractory or recurrent benign oesophageal stenosis” is now available. Find the Rapid Assessment here.
[CLOSED] Public consultation on the position paper on how to decide on the appropriate study design for primary research arising from HTA
In order to gather as much feedback as possible, WP7 Subgroup 2 has decided to extend the public consultation period on the Position paper on how to decide on the appropriate study design until May 29, 2015 at 12:00 noon CET. Objective of the position paper This document is one of two WP7 SG2 methodological […]
